Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation

Omer Jamy, MD, Racquel Innis-Shelton, MD, Susan Bal, MDMBBS, Ravi K. Paluri, MD, Samina Karim, Joseph H. Chewning, MD, Donna Salzman, MD, Luciano J. Costa, MD PhD, Antonio Di Stasi, MD, Lawrence S. Lamb, Jr., PhD, Shin Mineishi, Ayman Saad, MD

Blood (2019) 134 (Supplement_1): 2003.

https://doi.org/10.1182/blood-2019-129536

Published: 2019

Journal Articles

Autologous Hematopoietic Progenitor Cells Mobilization with Combination of Pegfilgrastim and Plerixafor: Efficacy and Cost Assessment

Luciano J. Costa, MD PhD, Racquel Innis-Shelton, MD, Joscelyn Bowersock, MT, Ayman Saad, MD, Donna Salzman, MD, Antonio Di Stasi, MD, Nicole Watts, PharmD, Lawrence S. Lamb, Jr., PhD

Blood (2017) 130 (Supplement 1): 4708.

https://doi.org/10.1182/blood.V130.Suppl_1.4708.4708

Published: 2017

Journal Articles

Decline in Late Mortality after Allogeneic Blood or Marrow Transplantation (alloBMT) Performed in Childhood: a Report from the BMT Survivor Study-2 (BMTSS-2)

Anna Sallfors Holmqvist, MD PhD, Yanjun Chen, MS, Jessica Wu, BA, Lindsey Hageman, MPH, Liton F. Francisco, BS, Mariel Parman, MPH, Michelle Kung, MA, Emily Ness, MPH, Kevin D. Battles, BS, Ravi Bhatia, MD, Donna Salzman, MD, Jeanette Falck Winther, MD DMSc, Stephen J. Forman, MD, Joseph Rosenthal, MD MS, Daniel J. Weisdorf, MD, Saro H. Armenian, DO,MPH, Mukta Arora, MD, Smita Bhatia, MDMPH

Blood (2017) 130 (Supplement 1): 672.

https://doi.org/10.1182/blood.V130.Suppl_1.672.672

Published: 2017

Journal Articles

Reduction in Late Mortality after Autologous Blood or Marrow Transplantation (autoBMT) in Childhood - a Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)

Anna Sallfors Holmqvist, MD PhD, Yanjun Chen, MS, Jessica Wu, BA, Lindsey Hageman, MPH, Liton F. Francisco, BS, Mariel Parman, MPH, Michelle Kung, MA, Emily Ness, MPH, Kevin D. Battles, BS, Jeanette Falck Winther, MD DMSc, Joseph Rosenthal, MD MS, Ravi Bhatia, MD, Donna Salzman, MD, Stephen J. Forman, MD FACP, Daniel J. Weisdorf, MD, Saro H. Armenian, DO,MPH, Mukta Arora, MD, Smita Bhatia, MDMPH

Blood (2017) 130 (Supplement 1): 337.

https://doi.org/10.1182/blood.V130.Suppl_1.337.337

Published: 2017

Journal Articles

Carfilzomib Plus High Dose Melphalan Conditioning Prior to Autologous Hematopoietic Cell Transplantation Followed By Carfilzomib Maintenance in Patients with Relapsed Multiple Myeloma

Luciano J. Costa, MD PhD, Heather Landau, MD, Saurabh Chhabra, MD, Parameswaran Hari, MD MRCP, MS, Donna Salzman, MD, Ayman Saad, MD, Racquel Innis-Shelton, MD, Mehdi Hamadani, MD, Roni Tamari, MD, Kelly N. Godby, MD, Vladimir Petrovic, Lisa Williams, RN, Evelyn Orlando, Pamela M Dixon, RN, Sergio A. Giralt, MD

Blood (2016) 128 (22): 4630.

https://doi.org/10.1182/blood.V128.22.4630.4630

Published: 2016

Journal Articles

Immune Reconstitution and Chimerism in Allogeneic HSCT Patients Treated with Post-HSCT High Dose Cyclophosphamide As Prophylaxis Against GvHD

Paluri k Ravi, Samina Karim, Gretchen Cloud, Mary Lamb, Samantha Langford, Shin Mineishi, MD, Racquel-innis Shelton, Ayman Saad, MD, Donna Salzman, MD, Lawrence S. Lamb, PhD

Blood (2014) 124 (21): 2474.

https://doi.org/10.1182/blood.V124.21.2474.2474

Published: 2014

Journal Articles

Influence of Pre-Transplant Cytomegalovirus (CMV) Serostatus on Post-Transplant Viral Reactivation after Allogeneic Stem Cell Transplantation in Patients Receiving Post-Transplant Cyclophosphamide for Gvhd Prophylaxis

Ravi K. Paluri, MD, Racquel Shelton, Melissa Gazi, Lawrence S. Lamb, PhD, Ayman Saad, MD, Donna Salzman, MD, Antonio Di Stasi, MD, Shin Mineishi, MD

Blood (2014) 124 (21): 3864.

https://doi.org/10.1182/blood.V124.21.3864.3864

Published: 2014

Journal Articles

Post-Transplant Cyclophosphamide Following Myeloablative Peripheral Blood Stem Cell Transplantation: A Single Institutional Experience

Racquel Innis-Shelton, MD, Donna Salzman, MD, Antonio Di Stasi, MD, Lawrence S. Lamb, PhD, Melissa Gazi, Lisa Williams, RN, Luciano J Costa, MD PhD, Harry Erba, Shin Mineishi, MD, Ayman Saad, MD

Blood (2014) 124 (21): 3911.

https://doi.org/10.1182/blood.V124.21.3911.3911

Published: 2014

NARROW

A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation

Autologous Hematopoietic Progenitor Cells Mobilization with Combination of Pegfilgrastim and Plerixafor: Efficacy and Cost Assessment

Decline in Late Mortality after Allogeneic Blood or Marrow Transplantation (alloBMT) Performed in Childhood: a Report from the BMT Survivor Study-2 (BMTSS-2)

Reduction in Late Mortality after Autologous Blood or Marrow Transplantation (autoBMT) in Childhood - a Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)

Carfilzomib Plus High Dose Melphalan Conditioning Prior to Autologous Hematopoietic Cell Transplantation Followed By Carfilzomib Maintenance in Patients with Relapsed Multiple Myeloma

Immune Reconstitution and Chimerism in Allogeneic HSCT Patients Treated with Post-HSCT High Dose Cyclophosphamide As Prophylaxis Against GvHD

Influence of Pre-Transplant Cytomegalovirus (CMV) Serostatus on Post-Transplant Viral Reactivation after Allogeneic Stem Cell Transplantation in Patients Receiving Post-Transplant Cyclophosphamide for Gvhd Prophylaxis

Post-Transplant Cyclophosphamide Following Myeloablative Peripheral Blood Stem Cell Transplantation: A Single Institutional Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only